Article
Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga
6 Nov 2019
Abstract excerpt
Immunotherapy with immune checkpoint inhibitors is an approved treatment option for a subpopulation of patients with colorectal cancers that display microsatellite instability. However, not all individuals within this subgroup respond to immunotherapy, and molecular biomarkers for effective patient stratification are still lacking. In this opinion article, we provide an overview of the different biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
